Gilead, Other Biotechs Selling Off On Market Weakness


Market mayhem continues, as Gilead Sciences, Inc. and other biotech companies are selling off on Monday's market weakness. Gilead Science's weekly performance is hovering around -5.75 percent and the issue has a YTD performance of -3.5 percent.



from Biotech News